Manejo de la eritropoyetina humana recombinante en pacientes con enfermedad renal crónica en estadio IV

The dosage required to achieve the hematocrit and hemoglobin values recommended by the National Kidney Foundation Disease Outcomes Quality Initiative (NKF-DOQI) was 50 to 75 UI/kg/week in predialysis patients. No significant changes were observed in blood pressure, side effects were minimal, and residual renal function remained stable.